Captura de pantalla 2023-08-08 105128

EIC Accelerator winners and statistics March 2023: €261 million for European deep-techs

The EIC Accelerator is a funding programme under Horizon Europe that offers support to start-ups and SMEs in the form of grants and investments to bring game-changing innovations to the market. 

The second EIC 2023 call closed on March 22, 2023, when a new set of companies were awarded by the European Innovation Council to receive funding. Results have been recently published:

  • 51 companies have been funded by the EIC in the March 2023 call (an increase by 59% compared to the previous call) with a total budget of €261M (33% increase in budget),
  • The selected companies spread across 17 countries, but the top three countries in this call have been the Netherlands (14%), France (12%), Israel and UK (9% each).
  • Blended Finance has been the most awarded financing type (45%).

551 proposals were submitted for this call (an increase by 15%), and 139 reached the interview stage (25% success rate). Although this call has not been as competitive as the January call, the selected companies have gone through a challenging and competitive process where only 51 of them (9% success rate at Step 3) have been awarded (19 more companies compared to the previous one, that is, an increase by 12% in success rates).

Almost 30% percent of the winners (15 of the 51 companies) have a female CEO, CTO (Chief Technology Officer) or CSO (Chief Scientific Officer).

More companies have been funded through this call which also represents an increase in budget: this time, the total awarded funding amounts to €261 million in a combination of grants and equity investments, which will be paid through the EIC Fund.

The geographical focus of the winners spreads across 17 countries,  including three widening countries, being Netherlands (14%), France (12%), Israel and UK (9% each) the countries on the top of the chart:

EIC winners per country March 2023

Figure 1. Number of EIC winners per country

Most awarded projects belong to blended finance (23 out of 51 proposals, 45%), followed by grant first (22 out of 51 applications, 43%) and, finally, grant only (6 out of 51 proposals, 12%).

Share of winning projects by financing type EIC March 2023 call

Figure 2. Share of winning projects by financing type

The 51 awarded projects can be classified into three categories: New deep-tech technologies & ICT; Health & Medical care; and Environment. Health has been the most awarded area with 27 out of 51 projects (52.94%), followed by new deep-tech technologies and ICT (17 out of 51 projects, 33.33%), and, finally, environment (7 out of 51, 13.72%).

Share of winning projects by innovation area EIC March 2023 call

Figure 3. Share of winning projects by innovation area.

The table below includes the full list of winners, including our friends from ENERPOLY, the Swedish startup disrupting the battery market through its unique and environmentally friendly zinc-ion battery cells and packs for stationary storage. Congratulations to all winners!

Company NameProposal AcronymShort DescriptionRecommended Financing TypeWebsiteCountry
ContextflowGMBHScaling generation AI chest CTIntegrated AI-based Clinical Decision Support for RadiologistsBlended financehttps://contextflow.com/ Austria
Arcsec NVDeDUSTDebris Detection Using Star TrackersGrant onlyhttps://www.arcsec.space/ Belgium
Convert Pharmaceuticals S.ATUMAGNOSTICA disruptive hypoxia activated prodrug for the treatment of resistant cancers: an AI-driven approachBlended financewww.convertpharma.com Belgium
Rehaler ApSPAREMAPArtial REbreathing for Migraine with AuraGrant firstwww.rehaler.com Denmark
SUBRA A/SSUBRACABLEMaking Superconducting power grids a feasible solution for EuropeGrant firsthttps://www.subra.dk/ Denmark
Better Medicine OÜBMAIEmpowering Radiologists in Cancer Diagnostics with Artificial IntelligenceGrant firsthttps://www.bettermedicine.ai/ Estonia
GeneCode ASKevadBioDeveloping a novel Parkinson’s disease drug using small molecule mimetics of Glial cell line-Derived Neurotrophic Factor (GDNF)Grant firsthttps://genecode.com/ Estonia
Ligneasy OyLignEasyWorlds first sulfuric acid-free kraft lignin recovery systemGrant firsthttps://www.ligneasy.fi/ Finland
CephalgoADAPTEA novel and accurate emotion recognition system for real-time and continuous patient monitoring in psychiatryGrant firsthttps://cephalgo.com/language/en/ France
DIOGENX SASDiogenXBeta-cell recovery to counter diabetesBlended financehttps://diogenx.com/ France
Giskard AI (SAS)GiskardQuality Assurance for AIGrant firsthttps://www.giskard.ai/ France
GREENERWAVEGreenerwaveThe first high-performance, low-cost flat panel antenna terminal at Ka band to unlock the full potential of satellite-based broadband communicationsBlended financewww.greenerwave.com France
PLENESYShyplasmaA clean and cost competitive hydrogen production solution near the end user thanks to an innovative plasma methane pyrolysis technologyBlended financewww.plenesys.com France
PanntherapiPANNEXINPannexin 1 – a novel target for pediatric orphan epilepsyGrant firsthttps://panntherapi.com/ France
Cellbox-Solutions GmbHCELLBOXInnovative transport of “in culture” cell-based materials ensuring product safety, quality and functionBlended financehttps://cellbox-solutions.com/ Germany
LUBIS EDA GmbHOverSemiOptimisation of a novel software tool for automation of the design & verification process of semiconductor developmentGrant firsthttps://lubis-eda.com/ Germany
Angiolutions GmbHSTAAART SmarT Abdominal Aortic AneuRysm TreatmentWorld’s first device-based treatment for small abdominal aortic aneurysms based on revolutionary new treatment paradigmGrant firsthttps://angiolutions.com Germany
Twinsity GmbHTwinspectFirst fast and automated (<5 min) AI-based inspection to increase operational safety of large critical infrastructure, e.g., bridges, dams, and oil & gas platforms and refineries Blended financehttps://twinsity.com/ Germany
BIOSIMULYTICS LIMITEDbiosim m2mBioSim M2M: Molecules to MedicineGrant firsthttps://www.biosimulytics.ai/?hsLang=enIreland
Celtic Biotech LtdCB24Development of a natural therapeutic treatment for late-stage lung cancer patientsGrant firsthttps://celticbiotech.com/ Ireland
Luminate Medical LimitedLILYLILY: A Breakthrough Technology to Prevent Chemotherapy-Induced Hair LossBlended financehttps://www.luminatemed.com/ Ireland
Hooke Bio LtdMEra – Micro EraMera – Ethical, accurate drug developmentBlended financewww.hookebio.com Ireland
Escala Medical LTDapyxThe first non-surgical repair for Pelvic Organ ProlapseBlended financehttp://www.escalamedical.com/ Israel
Butterfly Medical Ltd.MPRDInnovative, minimally invasive Medical Prostatic Retraction Device for the treatment of Benign Prostatic Hyperplasia (BPH) Patients in the office settings.Blended financehttps://butterfly-medical.com/ Israel
NeuReality LTDNR1AI-centric Server on Chip for increasing complexity and scale of AI inference applications, enabling the scale of real-life AI applicationsBlended financehttps://www.neureality.ai/ Israel
BIOPROTECT LTDProSpaceBioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosageBlended financehttps://www.bioprotect.com/ Israel
X-trodes LtdS-trodesReliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsordersBlended financehttps://xtrodes.com/ Israel
Finapp srlfinapp cosmic ray neutron sensingScaling up the FINAPP Cosmic Ray Neutron Sensing probeGrant firsthttps://www.finapptech.com/ Italy
HPCC System srlNbyNThe New Generation Needle by Needle Knitting MachineGrant firsthttp://www.hpccsystem.com/ Italy
MORPHOTONICS BVAR-R2PMass Manufacturing Augmented Reality (AR) Waveguides via Roll-to-Plate NanoimprintingGrant firsthttps://www.morphotonics.com/ Netherlands
Stentit B.VEX-STENTTHE NEXT STENT GENERATION: A FIRST-IN-CLASS REGENERATIVE NANOFIBER STENT TO RECONSTRUCT ARTERIES FROM THE INSIDE OUTBlended financehttps://www.stentit.com/ Netherlands
ORANGE QUANTUM SYSTEMS OPERATIONAL BVHTQC-DiagnosticsHigh-Throughput Quantum Chip DiagnosticsGrant firsthttps://orangeqs.com/ Netherlands
Genewity B.V.i-THYMUSThe i-Thymus: wielding the potential of gene therapy, cell therapy and induced pluripotent stem cells for the regeneration of the thymus and the adaptive immune systemGrant firsthttp//:www.genewity.tech Netherlands
THIRONA BVLungQ-CareFacilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support SystemGrant firsthttps://thirona.eu/ Netherlands
Magneto B.V.Magnetocaloric heating and coolingDisrupting the cooling and heating industry: a revolutionary green, energy efficient and cost competitive magnetocaloric technology platformGrant firsthttps://magneto.systems/ Netherlands
Mu-G Knowledge Management BVPATSPATS: Eliminating pesticides!Blended financewww.pats-drones.com Netherlands
PAMGENE INTERNATIONAL BVROUTINEcanceR agnOstic immUnoTherapy predIctioN blood-tEstBlended financehttps://pamgene.com/ Netherlands
Excess Engineering ASElectric Actuator (The missing link)Electrification of heavy machineryBlended financewww.excessengineering.no Norway
PICTERUS ASPicterus Jaundice mHealth platformBringing newborn care home: An integral mHealth solution for neonatal jaundice managementGrant firsthttps://www.picterus.com/ Norway
SGPR.TECH SPLOKA Z OGRANICZONA ODPOWIEDZIALNOSCIAWIDMO CitiesProviding complete subsurface information of the urban areasBlended financewww.widmo.techPoland
Hydrumedical, S.AHYDRUSTENTHydrogel Biodegradable Ureteral StentBlended financewww.hydrumedical.pt Portugal
Oils4cure S.L.oils4cureOils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous SclerosisGrant firsthttps://oils4cure.com/home/ Spain
MiMARK Diagnostics, S.LWomECReshaping women’s health through the understanding of gynecological fluids. WomEC: Antibody-based IVD test based on 5 novel protein biomarkers quantified in liquid biopsyGrant firsthttps://www.mimark.es/ Spain
ENERPOLY ABEUROZIPEUROZIP: European Zinc-Ion PlantBlended financewww.enerpoly.com Sweden
NEOGAP Therapeutics ABNEOpTTLInnovative approach to an Individualised T-Cell Immunotherapy for cancer, using Personalised Tumour Trained Lymphocytes (pTTL) that is reliable, cost-effective, scalable and easy to implementBlended financewww.neogap.se Sweden
Molecular Attraction ABSemioMVCMosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector controlBlended financehttps://www.molecular-attraction.com Sweden
Lumi Space LtdLumi SLRRevolutionising space sustainability through precise and scalable Satellite Laser RangingGrant onlyhttps://www.lumi.space/ United Kingdom
CRYPTO QUANTIQUE LIMITEDQRYPTONQuantum secuRe crYptograPhy to secure IoT devices in deep submicrOn NodesGrant onlyhttps://www.cryptoquantique.com/ United Kingdom
Newrotex LimitedThe Oxford Nerve ConduitA breakthrough silk-based solution for treatment of peripheral nerve injuryGrant onlyhttps://www.newrotex.com/ United Kingdom
Wave Photonics Ltd.Wave PhotonicsThe platform to unleash the transformative potential of integrated photonicsGrant onlyhttps://www.wavephotonics.com/ United Kingdom
Zero Point Motion LtdZPM IMUZERO POINT MOTION LTDGrant onlyhttps://zeropointmotion.com United Kingdom

Share this post

related post

Featured insights

A fast check for your hockey stick financials

Run this fast check before presenting your hockey stick financial projections to investors! Let’s face it: most startups say they are innovative and their business